Tuya: Quiet Execution, Strong Margins, And A Billion-Dollar Cash Cushion

Tuya (TUYA) stock is growing profits, has strong cash, no debt, and its AI expansion signals future upside. See here know why ...

Amgen: FDA Approves Tezspire For Chronic Rhinosinusitis With Nasal Polyps

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- ...